PARIS (AP) -- French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion, ending months of corporate haggling....
biotechnology companySanofi-Aventis to buy Genzyme for $20.1 bln cashHeadlines from the Associated Press Wed, 02/16/2011 - 03:45
PARIS (AP) -- French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion, ending months of corporate haggling.... Cancer Research Institute invests $450k in Oncovir to manufactur...EurekAlert! - Cancer Thu, 01/20/2011 - 23:00
(Cancer Research Institute) The Cancer Research Institute, a nonprofit organization, has partnered with the biotechnology company Oncovir, Inc., to produce clinical grade poly-ICLC (Hiltonol), a powerful immune stimulant, for testing in trials of cancer vaccines and other immunotherapies. Tags:
First-ever covalent irreversible inhibition of a protease centra...EurekAlert! - Medicine and Health Sat, 11/27/2010 - 23:00
(Yates Public Relations) Avila, a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug. Tags:
Genentech says FDA approves Actemra arthritis drugHeadlines from the Associated Press Sat, 01/09/2010 - 16:34
SOUTH SAN FRANCISCO, Calif. (AP) -- Biotechnology company Genentech Inc. says the U.S. Food and Drug Administration has approved its new drug to treat rheumatoid arthritis.... Tags:
FDA finds bits of steel, rubber in Genzyme drugsHeadlines from the Associated Press Fri, 11/13/2009 - 15:23
WASHINGTON (AP) -- Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues.... |